top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2008; 1:354-362, doi:10.1016/j.jcmg.2007.11.007
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View CVN Interview
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Verjans, J. W.H.
Right arrow Articles by Narula, J.
PubMed
Right arrow Articles by Verjans, J. W.H.
Right arrow Articles by Narula, J.
Related Collections
Right arrowRelated Article

Clinical research

Noninvasive Imaging of Angiotensin Receptors After Myocardial Infarction

Johan W.H. Verjans, MD*,||, Dagfinn Lovhaug, PhD§, Navneet Narula, MD{dagger}, Artiom D. Petrov, PhD*, Bård Indrevoll, MS§, Emma Bjurgert, PhD§, Tatiana B. Krasieva, PhD{ddagger}, Lizette B. Petersen, MS§, Grete M. Kindberg, PhD§, Magne Solbakken, PhD§, Alan Cuthbertson, PhD§, Mani A. Vannan, MD, FACC*, Chris P.M. Reutelingsperger, PhD||, Bruce J. Tromberg, PhD{ddagger}, Leonard Hofstra, MD, PhD||, Jagat Narula, MD, PhD, FACC*,*

* Department of Cardiology, University of California at Irvine, Irvine, California
{dagger} Department of Pathology, University of California at Irvine, Irvine, California
{ddagger} Beckman Laser Institute, University of California at Irvine, Irvine, California
§ GE Healthcare, Oslo, Norway
|| Cardiovascular Research Institute, Maastricht University, Maastricht, the Netherlands.

* Reprint requests and correspondence: Dr. Jagat Narula OR Dr. Leo Hofstra, University of California, Irvine, School of Medicine, 101 The City Drive, Bldg. 53, Mail Route 81, Orange, California 92868-4080. (Email: l.hofstra{at}cardio.unimaas.nl; narula{at}uci.edu).

Objectives: The purpose of this study was to evaluate the feasibility of noninvasive imaging of angiotensin II (AT) receptor upregulation in a mouse model of post-myocardial infarction (MI) heart failure (HF).

Background: Circulating AT levels do not reflect the status of upregulation of renin-angiotensin axis in the myocardium, which plays a central role in ventricular remodeling and evolution of HF after MI. Appropriately labeled AT or AT receptor blocking agents should be able to specifically target AT receptors by molecular imaging techniques.

Methods: AT receptor imaging was performed in 29 mice at various time points after permanent coronary artery ligation or in controls using a fluoresceinated angiotensin peptide analog (APA) and radiolabeled losartan. The APA was used in 19 animals for intravital fluorescence microscopy on a beating mouse heart. Tc-99m losartan was used for in vivo radionuclide imaging and quantitative assessment of AT receptor expression in 10 mice. After imaging, hearts were harvested for pathological characterization using confocal and 2-photon microscopy.

Results: No or little APA uptake was observed in control animals or within infarct regions on days 0 and 1. Distinct uptake occurred in the infarct area at 1 to 12 weeks after MI; the uptake was at maximum at 3 weeks and reduced markedly at 12 weeks after MI. Ultrasonographic examination demonstrated left ventricular remodeling, and pathologic characterization revealed localization of the APA tracer with collagen-producing myofibroblasts. Tc-99m losartan uptake in the infarct region (0.524 ± 0.212% injected dose/g) increased 2.4-fold as compared to uptake in the control animals (0.215 ± 0.129%; p < 0.05).

Conclusions: The present study demonstrates the feasibility of in vivo molecular imaging of AT receptors in the remodeling myocardium. Noninvasive imaging studies aimed at AT receptor expression could play a role in identification of subjects likely to develop heart failure. In addition, such a strategy could allow for optimization of anti-angiotensin therapy in patients after MI.

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  APA = angiotensin peptide analog
  AT = angiotensin II
  CT = computed tomography
  HF = heart failure
  LV = left ventricle
  MI = myocardial infarction
  SMA = smooth muscle actin
  SPECT = single-photon emission computed tomography


Related Article

Molecular Imaging of the Remodeling Heart: The Next Step Forward
Barry Greenberg
J. Am. Coll. Cardiol. Img. 2008 1: 363-365. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
B. Greenberg
Molecular Imaging of the Remodeling Heart: The Next Step Forward
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 363 - 365.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
J. Narula and V. Dilsizian
From Better Understood Pathogenesis to Superior Molecular Imaging, and Back...
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 406 - 409.
[Full Text] [PDF]



 
   
 
home link current link search link archive link topics link cardiology careers link